Estimating the true prevalence of an epidemic outbreak is a key public health problem. This is challenging because surveillance is usually resource intensive and biased. In the network setting, prior work on cost sensitive disease surveillance has focused on choosing a subset of individuals (or nodes) to minimize objectives such as probability of outbreak detection. Such methods do not give insights into the outbreak size distribution which, despite being complex and multi-modal, is very useful in public health planning. We introduce TESTPREV, a problem of choosing a subset of nodes which maximizes the mutual information with disease prevalence, which directly provides information about the outbreak size distribution. We show that, under the independent cascade (IC) model, solutions computed by all prior disease surveillance approaches are highly sub-optimal for TESTPREV in general. We also show that TESTPREV is hard to even approximate. While this mutual information objective is computationally challenging for general networks, we show that it can be computed efficiently for various network classes. We present a greedy strategy, called GREEDYMI, that uses estimates of mutual information from cascade simulations and thus can be applied on any network and disease model. We find that GREEDYMI does better than natural baselines in terms of maximizing the mutual information as well as reducing the expected variance in outbreak size, under the IC model.

Only a subset of infections is actually observed in an outbreak, due to multiple reasons such as asymptomatic cases and under-reporting. Therefore, reconstructing an epidemic cascade given some observed cases is an important step in responding to such an outbreak. A maximum likelihood solution to this problem ( referred to as CascadeMLE ) can be shown to be a variation of the classical Steiner subgraph problem, which connects a subset of observed infections. In contrast to prior works on epidemic reconstruction, which consider the standard Steiner tree objective, we show that a solution to CascadeMLE, based on the actual MLE objective, has a very different structure. We design a logarithmic approximation algorithm for CascadeMLE, and evaluate it on multiple synthetic and social contact networks, including a contact network constructed for a hospital. Our algorithm has significantly better performance compared to a prior baseline.

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria resistant to certain antibiotics, making it difficult to prevent MRSA infections. Among decades of efforts to conquer infectious diseases caused by MRSA, many studies have been proposed to estimate the causal effects of close contact (treatment) on MRSA infection (outcome) from observational data. In this problem, the treatment assignment mechanism plays a key role as it determines the patterns of missing counterfactuals --- the fundamental challenge of causal effect estimation. Most existing observational studies for causal effect learning assume that the treatment is assigned individually for each unit. However, on many occasions, the treatments are pairwisely assigned for units that are connected in graphs, i.e., the treatments of different units are entangled. Neglecting the entangled treatments can impede the causal effect estimation. In this paper, we study the problem of causal effect estimation with treatment entangled in a graph. Despite a few explorations for entangled treatments, this problem still remains challenging due to the following challenges: (1) the entanglement brings difficulties in modeling and leveraging the unknown treatment assignment mechanism; (2) there may exist hidden confounders which lead to confounding biases in causal effect estimation; (3) the observational data is often time-varying. To tackle these challenges, we propose a novel method NEAT, which explicitly leverages the graph structure to model the treatment assignment mechanism, and mitigates confounding biases based on the treatment assignment modeling. We also extend our method into a dynamic setting to handle time-varying observational data. Experiments on both synthetic datasets and a real-world MRSA dataset validate the effectiveness of the proposed method, and provide insights for future applications.